Leadership Team:

Rachel Whyte, Patient Partner
Brent Edwards, University of Calgary
Elizabeth Zimmerman, McGill University

Platform aims:

  • The focus of this platform will be on the mechanisms of bone metabolism, its impact on bone mass and quality, and how it is influenced by lifestyle factors, genetics and disease.
  • We will include bone, muscle, fat, joint, and neural interactions related to musculoskeletal health for common bone disorders and rare bone diseases spanning childhood to older age.
  • There is an emphasis on the identification of new pharmacological targets and novel use of drugs already available.
  • Methodologies such as imaging, biomechanics, and advanced analytics including machine learning are important and link to clinical research.